Marshall Wace, LLP Isoray, Inc. Transaction History

Marshall Wace, LLP

  • $72.2 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
BUY
N/A
18,971,733 New
18,971,733 $13.1 Million
Q4 2021

Feb 14, 2022
SELL
$0.38 - $0.68 $18,399 - $32,926
-48,421 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$0.58 - $0.79 $28,084 - $38,252
48,421 New
48,421 $31,000

Others Institutions Holding ISR

# of Institutions
4
Shares Held
287K
Call Options Held
0
Put Options Held
0
View Full List

About Isoray, Inc.

ISR Quotes by TradingView
  • Ticker ISR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 142,112,992
  • Market Cap $98.1M
  • Description
  • Isoray, Inc., through its subsidiary, IsoRay Medical, Inc., develops, manufactures, and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases in the United States and internationally. The company offers CS-1 Cesium-131 brachytherapy seeds for the treatment of prostate, brain, lung, head and nec...
More about ISR
Track This Portfolio

Track Marshall Wace, LLP Portfolio

Follow Marshall Wace, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email